Merck is making its fourth acquisition of the year, this time buying a single asset from a Shanghai-based cancer drug developer.
The New Jersey pharma …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
GSK’s blood cancer drug momelotinib has taken another turn on its winding journey, with the FDA delaying its review of the investigational tablet that GSK
Whether you’re a fan of the drug name Zepbound or, like one X user, think it sounds like “an off brand bus line,” you’re likely
How did the bodies of animals, including ours, become such fine-tuned movement machines? How vertebrates coordinate the eternal tug-o-war between involuntary reflexes and seamless voluntary